This retrospective study evaluated the prevalence of secondary psychosis among adults presenting with first-episode psychosis (FEP) to an acute medical setting in a predominantly Chinese metropolitan population in Hong Kong. Among 384 patients included, secondary causes were identified in 9.6% (n = 37) of cases. The authors note that this prevalence is lower than figures reported in international literature.
The study population comprised patients aged 18–64 years referred to the consultation psychiatry team at a tertiary acute teaching hospital from January 2015 to April 2025. Mean age was 40.0 ± 13.7 years and 69% of the cohort were female. Inclusion required confirmation of FEP by the consultation-liaison psychiatry team. Patients who were diagnosed with delirium were excluded from the analysis.
This is a retrospective observational review of medical records. The consultation psychiatry records and results of workup performed in the acute medical setting were examined to identify secondary causes of psychosis. The report states ethical approval was obtained from the Joint Chinese University of Hong Kong – New Territories East Cluster Clinical Research Ethics Committee. The manuscript indicates that data produced in the study are available upon reasonable request. The source does not provide further granularity in this abstract regarding the specific diagnostic criteria, detailed investigation protocols, or the full list of tests performed.
Overall, secondary causes accounted for 9.6% of FEP presentations in this cohort (n = 37/384). The most frequent single category identified was substance use, found in 11 patients, representing 2.9% of the overall FEP sample. The source lists substance use as the commonest secondary cause but does not provide a full breakdown of all other secondary etiologies or their individual counts beyond those specified below.
Of the patients with secondary psychoses, 16 had their underlying condition revealed only by the medical workup initiated in relation to the FEP presentation. In other words, these diagnoses were not apparent from past history or routine toxicology and were detected because clinicians pursued targeted investigation after the psychotic presentation.
Among these 16 cases, the most commonly uncovered diagnoses were autoimmune encephalitis (definitive or probable) in five patients and early-onset dementia in four patients. The study highlights these two diagnostic categories as notable causes that may present primarily with psychosis in adults and that can be identified through appropriate investigations. The source does not specify the exact investigative modalities, antibody testing results, imaging findings, or diagnostic criteria used to define definitive versus probable autoimmune encephalitis, nor does it provide detailed clinical features of the individual cases beyond these aggregate counts.
The authors emphasise clinician awareness of features that should raise suspicion for autoimmune encephalitis and early-onset dementia in patients presenting with FEP, especially when past medical history and toxicology screening are otherwise unremarkable. Because 16 patients had underlying disorders detected only after targeted workup for FEP, the study supports a low threshold for further investigation when clinical features suggest an organic or atypical cause of psychosis.
Specific red flags or decision rules are not detailed in the source abstract; the authors recommend vigilance but do not report prescriptive testing algorithms or thresholds in the provided text.
This report is a brief summary of a retrospective single-centre series; the abstract does not include full methodological granularity such as the complete list of secondary causes evaluated, diagnostic criteria applied for each condition, systematic screening protocols, or inter-rater reliability of diagnoses. The authors state that their observed prevalence is lower than international figures but do not quantify those comparisons in the abstract. More detailed data and supplementary materials are available from the authors on reasonable request according to the source.
Ethical approval and participant consent procedures are reported as followed, and the authors declare no competing interests.